Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription 08.03.2021 5 Am J Med 1 Antimicrob Agents Chemother 1 BMC Pediatr 8 BMJ 4 Epidemiol Infect 20 J Infect Dis 4 J Virol 6 JAMA 3 Lancet 4 N Engl J Med 2 PLoS Comput Biol 1 PLoS Med 30 PLoS One 3 Proc Natl Acad Sci U S A 2 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. FERREIRA JP, Epstein M, Zannad F
   The Decline of the Experimental Paradigm During the COVID-19 Pandemic: A Template for the Future.
   Am J Med. 2021;134:166-175.
   PubMed         Abstract available
   
   
2. KORMAN TM, McMahon JH
   Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment.
   Am J Med. 2021;134:e220-e221.
   PubMed        
   
   
3. ASHFORD JW, Gold JE, Huenergardt MA, Katz RBA, et al
   MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness.
   Am J Med. 2021;134:153-155.
   PubMed        
   
   
4. MEISENBERG BR
   Medical Staff Responses to COVID-19 'Data': Have We Misplaced Our Skeptic's Eye?
   Am J Med. 2021;134:151-152.
   PubMed        
   
   
5. GLATTER KA, Finkelman P
   History of the Plague: An Ancient Pandemic for the Age of COVID-19.
   Am J Med. 2021;134:176-181.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

6. TOMITA Y, Takeda M, Matsuyama S
   The anti-influenza virus drug favipiravir has little effect on replication of SARS-CoV-2 in cultured cells.
   Antimicrob Agents Chemother. 2021 Mar 1. pii: AAC.00020.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

7. MA Z, Idris S, Zhang Y, Zewen L, et al
   The impact of COVID-19 pandemic outbreak on education and mental health of Chinese children aged 7-15 years: an online survey.
   BMC Pediatr. 2021;21:95.
   PubMed         Abstract available
   
   

   
   BMJ

8. CAAN W
   Covid-19: Difficult decisions require reciprocal understanding among decision makers.
   BMJ. 2021;372:n462.
   PubMed        
   
   
9. BHOPAL R
   Defer vaccination of people who have had covid-19.
   BMJ. 2021;372:n465.
   PubMed        
   
   
10. CUNNINGHAM AL, McIntyre P, Subbarao K, Booy R, et al
    Vaccines for older adults.
    BMJ. 2021;372:n188.
    PubMed         Abstract available
    
    
11. LIU J, Zhang L, Yan Y, Zhou Y, et al
    Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries.
    BMJ. 2021;372:n415.
    PubMed         Abstract available
    
    
12. FONTANET A, Grant R, Greve-Isdahl M, Sridhar D, et al
    Covid-19: Keeping schools as safe as possible.
    BMJ. 2021;372:n524.
    PubMed        
    
    
13. MULLER-SEDGWICK U
    Optimal dosing interval for covid-19 vaccines: we need clinical trial evidence and to consider past infection.
    BMJ. 2021;372:n522.
    PubMed        
    
    
14. LUCAS SB
    Coronial necropsies show the indirect damage from covid-19.
    BMJ. 2021;372:n529.
    PubMed        
    
    
15. NIKOGOSIAN H, Kickbusch I
    The case for an international pandemic treaty.
    BMJ. 2021;372:n527.
    PubMed        
    
    

    
    Epidemiol Infect

16. KAMAR A, Maalouf N, Hitti E, El Eid G, et al
    Challenge of forecasting demand of medical resources and supplies during a pandemic: A comparative evaluation of three surge calculators for COVID-19.
    Epidemiol Infect. 2021;149:e51.
    PubMed         Abstract available
    
    
17. LEHMANN J, Giesinger JM, Rumpold G, Borena W, et al
    Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria.
    Epidemiol Infect. 2021;149:e52.
    PubMed         Abstract available
    
    
18. DUQUE MP, Lucaccioni H, Costa C, Marques R, et al
    COVID-19 symptoms: a case-control study, Portugal, March-April 2020.
    Epidemiol Infect. 2021;149:e54.
    PubMed         Abstract available
    
    
19. HONG K, Yum SJ, Kim JH, Chun BC, et al
    Re-estimation of basic reproduction number of COVID-19 based on the epidemic curve by symptom onset date.
    Epidemiol Infect. 2021;149:e53.
    PubMed         Abstract available
    
    

    
    J Infect Dis

20. GALANTI M, Shaman J
    Direct Observation of Repeated Infections With Endemic Coronaviruses.
    J Infect Dis. 2021;223:409-415.
    PubMed         Abstract available
    
    
21. HO HE, Peluso MJ, Margus C, Matias Lopes JP, et al
    Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV.
    J Infect Dis. 2020 Jun 30. pii: 5864898. doi: 10.1093.
    PubMed         Abstract available
    
    
22. FALSEY AR, Walsh EE
    Respiratory Syncytial Virus: An Old Foe in a New Era.
    J Infect Dis. 2020;222:1245-1246.
    PubMed        
    
    
23. TSENG HF, Sy LS, Ackerson B, Solano Z, et al
    Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection.
    J Infect Dis. 2020;222:1298-1310.
    PubMed         Abstract available
    
    
24. FILL MA
    Multistate Outbreak of Seoul Virus: Implications for the One Health Movement and Pandemic Preparedness.
    J Infect Dis. 2020;222:1247-1249.
    PubMed        
    
    
25. SIEDNER MJ, Gandhi RT, Kim AY
    Desperate Times Call for Temperate Measures: Practicing Infectious Diseases During a Novel Pandemic.
    J Infect Dis. 2020;222:1084-1085.
    PubMed        
    
    
26. OFMAN G, Pradarelli B, Caballero MT, Bianchi A, et al
    Respiratory Failure and Death in Vulnerable Premature Children With Lower Respiratory Tract Illness.
    J Infect Dis. 2020;222:1129-1137.
    PubMed         Abstract available
    
    
27. HAYDEN FG, Whitley RJ
    Respiratory Syncytial Virus Antivirals: Problems and Progress.
    J Infect Dis. 2020;222:1417-1421.
    PubMed        
    
    
28. ZENG QL, Yu ZJ, Ji F
    Reply to Rabelo-da-Ponte et al.
    J Infect Dis. 2020;222:1578.
    PubMed        
    
    
29. MAROSSY A, Rakowicz S, Bhan A, Noon S, et al
    A Study of Universal Severe Acute Respiratory Syndrome Coronavirus 2 RNA Testing Among Residents and Staff in a Large Group of Care Homes in South London.
    J Infect Dis. 2021;223:381-388.
    PubMed         Abstract available
    
    
30. LIM JT, Chew LZX, Choo ELW, Dickens BSL, et al
    Increased Dengue Transmissions in Singapore Attributable to SARS-CoV-2 Social Distancing Measures.
    J Infect Dis. 2021;223:399-402.
    PubMed         Abstract available
    
    
31. CHORENO-PARRA JA, Jimenez-Alvarez LA, Ramirez-Martinez G, Cruz-Lagunas A, et al
    Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19.
    J Infect Dis. 2021 Mar 1. pii: 6154795. doi: 10.1093.
    PubMed         Abstract available
    
    
32. BULFONE TC, Malekinejad M, Rutherford GW, Razani N, et al
    Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review.
    J Infect Dis. 2021;223:550-561.
    PubMed         Abstract available
    
    
33. LERSY F, Benotmane I, Helms J, Collange O, et al
    Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
    J Infect Dis. 2021;223:600-609.
    PubMed         Abstract available
    
    
34. TRIEU MC, Bansal A, Madsen A, Zhou F, et al
    SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    J Infect Dis. 2021;223:589-599.
    PubMed         Abstract available
    
    
35. SINHA P, Jafarzadeh SR, Assoumou SA, Bielick CG, et al
    The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.
    J Infect Dis. 2021;223:581-588.
    PubMed         Abstract available
    
    
36. BEDIN AS, Makinson A, Picot MC, Mennechet F, et al
    Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019.
    J Infect Dis. 2021;223:562-567.
    PubMed         Abstract available
    
    
37. LI A, Ling Y, Song Z, Cheng X, et al
    Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;223:568-580.
    PubMed         Abstract available
    
    
38. MUECKSCH F, Wise H, Batchelor B, Squires M, et al
    Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients.
    J Infect Dis. 2021;223:389-398.
    PubMed         Abstract available
    
    
39. GOLDSTEIN E, Lipsitch M, Cevik M
    On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community.
    J Infect Dis. 2021;223:362-369.
    PubMed         Abstract available
    
    

    
    J Virol

40. LEE E, Sandgren K, Duette G, Stylianou VV, et al
    Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity.
    J Virol. 2020 Dec 21. pii: JVI.02002-20. doi: 10.1128/JVI.02002.
    PubMed         Abstract available
    
    
41. LUO Z, Girton AW, Heaton BE, Heaton NS, et al
    Engineered influenza virions reveal the contributions of non-hemagglutinin structural proteins to vaccine mediated protection.
    J Virol. 2021 Mar 3. pii: JVI.02021-20. doi: 10.1128/JVI.02021.
    PubMed         Abstract available
    
    
42. PHAN T, Fay EJ, Lee Z, Aron S, et al
    Segment-specific kinetics of mRNA, cRNA and vRNA accumulation during influenza infection.
    J Virol. 2021 Mar 3. pii: JVI.02102-20. doi: 10.1128/JVI.02102.
    PubMed         Abstract available
    
    
43. GONG W, He X, Huang K, Zhang Y, et al
    Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly.
    J Virol. 2021 Mar 3. pii: JVI.00008-21. doi: 10.1128/JVI.00008.
    PubMed         Abstract available
    
    

    
    JAMA

44. FAUST JS, Krumholz HM, Du C, Mayes KD, et al
    All-Cause Excess Mortality and COVID-19-Related Mortality Among US Adults Aged 25-44 Years, March-July 2020.
    JAMA. 2020 Dec 16. pii: 2774445. doi: 10.1001/jama.2020.24243.
    PubMed        
    
    
45. LOPEZ L 3RD, Hart LH 3rd, Katz MH
    Racial and Ethnic Health Disparities Related to COVID-19.
    JAMA. 2021 Jan 22. pii: 2775687. doi: 10.1001/jama.2020.26443.
    PubMed        
    
    
46. PIZZO PA, Spiegel D, Mello MM
    When Physicians Engage in Practices That Threaten the Nation's Health.
    JAMA. 2021;325:723-724.
    PubMed        
    
    
47. MEISSNER HC
    A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events.
    JAMA. 2021 Feb 5. pii: 2776308. doi: 10.1001/jama.2020.26792.
    PubMed        
    
    
48. MEEKS LM
    COVID-19 Communication-The Need for Humanity, Empathy, and Grace.
    JAMA. 2021;325:725-726.
    PubMed        
    
    
49. CHOKSHI DA
    From Economic Recovery to Health Resilience.
    JAMA. 2021;325:710-711.
    PubMed        
    
    

    
    Lancet

50. MARCHALIK D, Lipsky A
    Transformative experiences and A Young Doctor's Notebook.
    Lancet. 2021;397:270.
    PubMed        
    
    
51. LAU E, Wang HH, Qiao J, Jiang B, et al
    Wakley-Wu Lien Teh Prize Essay 2020: passing the baton to the next generation of health workers.
    Lancet. 2021;397:261-262.
    PubMed        
    
    
52. JAFFE S
    Rochelle Walensky: new Director of the US CDC.
    Lancet. 2021;397:268.
    PubMed        
    
    

    
    N Engl J Med

53. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination.
    N Engl J Med. 2021;384:e40.
    PubMed        
    
    
54. NORMAND ST
    The RECOVERY Platform.
    N Engl J Med. 2021;384:757-758.
    PubMed        
    
    
55. LANE HC, Fauci AS
    Research in the Context of a Pandemic.
    N Engl J Med. 2021;384:755-757.
    PubMed        
    
    
56. HORBY P, Lim WS, Emberson JR, Mafham M, et al
    Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.
    N Engl J Med. 2020 Jul 17. doi: 10.1056/NEJMoa2021436.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

57. TREVEIL A, Bohar B, Sudhakar P, Gul L, et al
    ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways.
    PLoS Comput Biol. 2021;17:e1008685.
    PubMed         Abstract available
    
    
58. NANDE A, Adlam B, Sheen J, Levy MZ, et al
    Dynamics of COVID-19 under social distancing measures are driven by transmission network structure.
    PLoS Comput Biol. 2021;17:e1008684.
    PubMed         Abstract available
    
    

    
    PLoS Med

59. LAFOND KE, Porter RM, Whaley MJ, Suizan Z, et al
    Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003550.
    PubMed         Abstract available
    
    

    
    PLoS One

60. HULME OJ, Wagenmakers EJ, Damkier P, Madelung CF, et al
    A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19.
    PLoS One. 2021;16:e0245048.
    PubMed         Abstract available
    
    
61. UMAR Z, Gubareva M, Naeem M, Akhter A, et al
    Return and volatility transmission between oil price shocks and agricultural commodities.
    PLoS One. 2021;16:e0246886.
    PubMed         Abstract available
    
    
62. HENZI A, Kleger GR, Hilty MP, Wendel Garcia PD, et al
    Probabilistic analysis of COVID-19 patients' individual length of stay in Swiss intensive care units.
    PLoS One. 2021;16:e0247265.
    PubMed         Abstract available
    
    
63. BENHAM JL, Lang R, Kovacs Burns K, MacKean G, et al
    Attitudes, current behaviours and barriers to public health measures that reduce COVID-19 transmission: A qualitative study to inform public health messaging.
    PLoS One. 2021;16:e0246941.
    PubMed         Abstract available
    
    
64. EDIFOR EE, Brown R, Smith P, Kossik R, et al
    Non-Adherence Tree Analysis (NATA)-An adherence improvement framework: A COVID-19 case study.
    PLoS One. 2021;16:e0247109.
    PubMed         Abstract available
    
    
65. HOERTEL N, Sanchez-Rico M, Vernet R, Jannot AS, et al
    Observational study of haloperidol in hospitalized patients with COVID-19.
    PLoS One. 2021;16:e0247122.
    PubMed         Abstract available
    
    
66. DIEZ-MANGLANO J, Solis-Marquinez MN, Alvarez Garcia A, Alcala-Rivera N, et al
    Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry.
    PLoS One. 2021;16:e0247422.
    PubMed         Abstract available
    
    
67. KARDANI K, Bolhassani A
    Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
    PLoS One. 2021;16:e0247396.
    PubMed         Abstract available
    
    
68. LAKE EA, Demissie BW, Gebeyehu NA, Wassie AY, et al
    Knowledge, attitude and practice towards COVID-19 among health professionals in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0247204.
    PubMed         Abstract available
    
    
69. TRIUKOSE S, Nitinawarat S, Satian P, Somboonsavatdee A, et al
    Effects of public health interventions on the epidemiological spread during the first wave of the COVID-19 outbreak in Thailand.
    PLoS One. 2021;16:e0246274.
    PubMed         Abstract available
    
    
70. BRANDTNER C, Bettencourt LMA, Berman MG, Stier AJ, et al
    Creatures of the state? Metropolitan counties compensated for state inaction in initial U.S. response to COVID-19 pandemic.
    PLoS One. 2021;16:e0246249.
    PubMed         Abstract available
    
    
71. GOMEZ J, Prieto J, Leon E, Rodriguez A, et al
    INFEKTA-An agent-based model for transmission of infectious diseases: The COVID-19 case in Bogota, Colombia.
    PLoS One. 2021;16:e0245787.
    PubMed         Abstract available
    
    
72. AJIBOLA G, Bennett K, Powis KM, Hughes MD, et al
    Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines.
    PLoS One. 2020;15:e0244100.
    PubMed         Abstract available
    
    
73. GEBRETSADIK D, Ahmed N, Kebede E, Gebremicheal S, et al
    Knowledge, attitude, practice towards COVID-19 pandemic and its prevalence among hospital visitors at Ataye district hospital, Northeast Ethiopia.
    PLoS One. 2021;16:e0246154.
    PubMed         Abstract available
    
    
74. TSORI Y, Granek R
    Epidemiological model for the inhomogeneous spatial spreading of COVID-19 and other diseases.
    PLoS One. 2021;16:e0246056.
    PubMed         Abstract available
    
    
75. RUIZ-QUINONEZ JA, Guzman-Priego CG, Nolasco-Rosales GA, Tovilla-Zarate CA, et al
    Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
    PLoS One. 2021;16:e0245394.
    PubMed         Abstract available
    
    
76. SPOGIS J, Hagen F, Thaiss WM, Hoffmann T, et al
    Sonographic findings in coronavirus disease-19 associated liver damage.
    PLoS One. 2021;16:e0244781.
    PubMed         Abstract available
    
    
77. FRANZEN A, Wohner F
    Coronavirus risk perception and compliance with social distancing measures in a sample of young adults: Evidence from Switzerland.
    PLoS One. 2021;16:e0247447.
    PubMed         Abstract available
    
    
78. LOUREIRO CL, Jaspe RC, D Angelo P, Zambrano JL, et al
    SARS-CoV-2 genetic diversity in Venezuela: Predominance of D614G variants and analysis of one outbreak.
    PLoS One. 2021;16:e0247196.
    PubMed         Abstract available
    
    
79. COHEN AA, Yang Z, Gnanapragasam PNP, Ou S, et al
    Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers.
    PLoS One. 2021;16:e0247963.
    PubMed         Abstract available
    
    
80. MUSSINI C, Cozzi-Lepri A, Menozzi M, Meschiari M, et al
    Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection.
    PLoS One. 2021;16:e0247275.
    PubMed         Abstract available
    
    
81. FLIEDER T, Vollmer T, Muller B, Dreier J, et al
    Retrospective analysis of 426 donors of a convalescent collective after mild COVID-19.
    PLoS One. 2021;16:e0247665.
    PubMed         Abstract available
    
    
82. RISTIC M, Nikolic N, Cabarkapa V, Turkulov V, et al
    Validation of the STANDARD Q COVID-19 antigen test in Vojvodina, Serbia.
    PLoS One. 2021;16:e0247606.
    PubMed         Abstract available
    
    
83. YUAN C, Wang H, Li K, Tang A, et al
    SARS-CoV-2 viral shedding characteristics and potential evidence for the priority for faecal specimen testing in diagnosis.
    PLoS One. 2021;16:e0247367.
    PubMed         Abstract available
    
    
84. MUGISHA JYT, Ssebuliba J, Nakakawa JN, Kikawa CR, et al
    Mathematical modeling of COVID-19 transmission dynamics in Uganda: Implications of complacency and early easing of lockdown.
    PLoS One. 2021;16:e0247456.
    PubMed         Abstract available
    
    
85. MILLER ZD, Freimund W, Dalenberg D, Vega M, et al
    Observing COVID-19 related behaviors in a high visitor use area of Arches National Park.
    PLoS One. 2021;16:e0247315.
    PubMed         Abstract available
    
    
86. KIM B, Kim S, Jang W, Jung S, et al
    Estimation of the case fatality rate based on stratification for the COVID-19 outbreak.
    PLoS One. 2021;16:e0246921.
    PubMed         Abstract available
    
    
87. ZAHRAN AM, El-Badawy O, Ali WA, Mahran ZG, et al
    Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer.
    PLoS One. 2021;16:e0246806.
    PubMed         Abstract available
    
    
88. SALBACH C, Mueller-Hennessen M, Biener M, Stoyanov KM, et al
    Validation of two severity scores as predictors for outcome in Coronavirus Disease 2019 (COVID-19).
    PLoS One. 2021;16:e0247488.
    PubMed         Abstract available
    
    
89. AL NAAM YA, Elsafi SH, Alkharraz ZS, Alfahad OA, et al
    Community practice of using face masks for the prevention of COVID-19 in Saudi Arabia.
    PLoS One. 2021;16:e0247313.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

90. THURNER S, Klimek P, Hanel R
    Reply to Kusmierz and Toyoizumi: A network-based explanation of why most COVID-19 infection curves are linear.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed        
    
    
91. KAPLAN RM, Milstein A
    Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
92. JI W, Li X, Chen S, Ren L, et al
    Transmission of SARS-CoV-2 via fomite, especially cold chain, should not be ignored.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed        
    
    

    
    Vaccine

93. GASPAR EB, De Gaspari E
    Avidity assay to test functionality of anti-SARS-Cov-2 antibodies.
    Vaccine. 2021;39:1473-1475.
    PubMed        
    
    
94. HAMPTON LM, Aggarwal R, Evans SJW, Law B, et al
    General determination of causation between Covid-19 vaccines and possible adverse events.
    Vaccine. 2021 Jan 29. pii: S0264-410X(21)00096.
    PubMed        
    
    

    
    Virology

95. NOMURA N, Matsuno K, Shingai M, Ohno M, et al
    Updating the influenza virus library at Hokkaido University -It's potential for the use of pandemic vaccine strain candidates and diagnosis.
    Virology. 2021;557:55-61.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: